
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1019 | 1035 | 1101 | 1094 | 1255 | 1423 |
Fund Return | 1.89% | 3.49% | 10.13% | 3.03% | 4.65% | 3.59% |
Place in category | 2326 | 1950 | 1578 | 1363 | 697 | 388 |
% in Category | 64 | 56 | 49 | 52 | 34 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Indosuez Cap Emergents C | 248.17M | 2.91 | -0.31 | 1.43 | ||
Indosuez Cap Emergents D | 248.17M | 2.90 | -0.31 | 1.44 | ||
Florissime Dynamisme | 20.82M | 3.17 | 5.80 | 4.12 | ||
Misukase C | 16.47M | 2.20 | 1.28 | 2.14 | ||
Danae | 11.73M | 2.46 | 2.32 | 4.67 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
R Valor C EUR | 6.41B | 3.39 | 8.03 | 8.29 | ||
R Valor D EUR | 6.41B | 3.39 | 8.03 | 8.30 | ||
R Valor F EUR | 6.41B | 3.36 | 7.65 | 7.83 | ||
R Valor P EUR | 6.41B | 3.43 | 8.57 | 8.77 | ||
CPR Croissance Reactive i | 1.03B | 1.06 | 2.39 | 2.30 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amundi Euro Liquid Shrt Trm SRI I C | FR0007435920 | 17.72 | - | - | |
Amundi Euro Liquidity-Rated SRI R | FR0013289386 | 17.12 | 105.836 | +0.01% | |
iShares China CNY Bond UCITS ETF USD Acc | IE00BKPSFD61 | 8.98 | 5.87 | -0.06% | |
Amundi Money Market Fund Short Term (USD) IV C | LU0567780803 | 8.50 | 1,227.482 | +0.01% | |
Lyxor Index Fund - Lyxor MSCI EMU Value (DR) UCITS | LU1598690169 | 7.87 | 146.50 | +0.85% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review